Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat

In bronchoalveolar lavage (BAL) of human immunodeficiency virus (HIV)-infected patients with Pneumocystis carinii pneumonia and in lungs of glucocorticoid-immunosuppressed rats infected with P. carinii, surfactant phospholipid levels are reduced. However, levels of the surfactant-associated protein-A (SP-A) in BAL are 4-5 times higher than normal in patients with P. carinii pneumonia. In this study, we examined the effects of glucocorticoid immunosuppression and P. carinii infection on SP-A messenger ribonucleic acid (mRNA) and protein levels in rat lungs. Rats were immunosuppressed by adding dexamethasone to their drinking water and were infected with P. carinii by intratracheal instillation of the organism. SP-A was measured by enzyme-linked immunosorbent assay (ELISA) and SP-A mRNA by hybridization of Northern blots with an SP-A complementary deoxyribonucleic acid (cDNA) probe. There was a severalfold increase in SP-A protein and mRNA levels in uninfected glucocorticoid-treated rats. However, contrary to what has been reported with the surfactant-associated lipids, SP-A mRNA and protein levels in P. carinii-infected animals were significantly higher than those found in the uninfected, immunosuppressed animals. Our results demonstrate that SP-A increases, probably as a result of elevated mRNA levels, in immunosuppressed rats with P. carinii infection and are consistent with our findings in HIV-positive patients with P. carinii pneumonia.

This article has been cited by other articles:

				M. Shibasaki, K. Hashimoto, M. Okamoto, Y. Hayashi, K. Imaizumi, N. Hashimoto, N. Ozaki, T. Yokoi, K. Takagi, Y. Hasegawa, et al. Up-Regulation of Surfactant Protein Production in a Mouse Model of Secondary Pulmonary Alveolar Proteinosis Am. J. Respir. Cell Mol. Biol., May 1, 2009; 40(5): 536 - 542. [Abstract] [Full Text] [PDF]

				Z. Wang, A. Foye, Y. Chang, P. R. Chess, T. W. Wright, S. Bhagwat, F. Gigliotti, and R. H. Notter Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1124 - L1131. [Abstract] [Full Text] [PDF]

				E. N. Atochina, J. M. Beck, A. M. Preston, A. Haczku, Y. Tomer, S. T. Scanlon, T. Fusaro, J. Casey, S. Hawgood, A. J. Gow, et al. Enhanced Lung Injury and Delayed Clearance of Pneumocystis carinii in Surfactant Protein A-Deficient Mice: Attenuation of Cytokine Responses and Reactive Oxygen-Nitrogen Species Infect. Immun., October 1, 2004; 72(10): 6002 - 6011. [Abstract] [Full Text] [PDF]

				J. A. Gold, Y. Hoshino, N. Tanaka, W. N. Rom, B. Raju, R. Condos, and M. D. Weiden Surfactant Protein A Modulates the Inflammatory Response in Macrophages during Tuberculosis Infect. Immun., February 1, 2004; 72(2): 645 - 650. [Abstract] [Full Text] [PDF]

				H. Wissel, C. Schulz, M. Rudiger, M. Krull, P. A. Stevens, and R. R. Wauer Chlamydia pneumoniae Affect Surfactant Trafficking and Secretion Due to Changes of Type II Cell Cytoskeleton Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 303 - 313. [Abstract] [Full Text] [PDF]

				E. N. Atochina, M. F. Beers, S. T. Scanlon, A. M. Preston, and J. M. Beck P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L599 - L609. [Abstract] [Full Text] [PDF]

				C. HERMANS and A. BERNARD Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678. [Full Text]

				E. C. Crouch Collectins and Pulmonary Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 177 - 201. [Abstract] [Full Text]

				R. J. Mason, K. Greene, and D. R. Voelker Surfactant protein A and surfactant protein D in health and disease Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L1 - L13. [Abstract] [Full Text] [PDF]

				J. A. Fishman Treatment of Infection Due to Pneumocystis carinii Antimicrob. Agents Chemother., June 1, 1998; 42(6): 1309 - 1314. [Full Text]

				H. Koziel, D. S. Phelps, J. A. Fishman, M. Y. K. Armstrong, F. F. Richards, and R. M. Rose Surfactant Protein-A Reduces Binding and Phagocytosis of Pneumocystis carinii by Human Alveolar Macrophages In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 1998; 18(6): 834 - 843. [Abstract] [Full Text]

				D. G. Baker Natural Pathogens of Laboratory Mice, Rats, and Rabbits and Their Effects on Research Clin. Microbiol. Rev., April 1, 1998; 11(2): 231 - 266. [Abstract] [Full Text] [PDF]